ZYBT
NASD Zhengye Biotechnology Holding Ltd. Class A$1.29 ↓ -0.01 (-1.02%) Trading Down from the previous close of $1.30, and at the day’s high of $1.29
- YTD change
- +11.89%
- vs 20-day SMA
- -12.37%
- vs 200-day SMA
- +10.08%
Price ranges
Price & Performance
+0.45 (+52.94%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 91.0% away from all-time highs of $14.30
- ZYBT is up 12% since the beginning of the year
- ZYBT is down 41% over the past 12 months
- ZYBT is down 26% over the past 1 month
- 3% of all ZYBT investors are betting against ZYBT
ZYBT reads poor: price sits above one of the two key moving averages, the 12-month move is -40.6%.
- Previous minute
- +$0.00
- Last hour
- -$0.00
- Last 5 days
- -4.69%
- vs 8-day SMA
- -3.39%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.